Examples abound of membrane-bound enzymes for which the local membrane environment plays an important role, including the ectoenzyme that triggers blood clotting: the plasma serine protease, factor VIIa, bound to the integral membrane protein, tissue factor. The activity of this enzyme complex is markedly influenced by lipid bilayer composition, and furthermore, tissue factor partitions into membrane microdomains on some cell surfaces. Unfortunately, little is known about how membrane microdomain composition controls factor VIIa-tissue factor activity, since reactions catalyzed by membrane-tethered enzymes are typically studied under conditions in which the experimenter cannot control the composition of the membrane in the immediate vicinity of the enzyme. In order to overcome this problem we used a nanoscale approach that afforded complete control over the membrane environment surrounding tissue factor, by assembling the factor VIIa-tissue factor complex on stable bilayers containing 67±1 phospholipid molecules per leaflet (Nanodiscs). We investigated how local changes in phospholipid bilayer composition modulate the activity of the factor VIIa-tissue factor complex. We also addressed whether this enzyme requires a pool of membrane-bound protein substrate (factor X) for efficient catalysis, or alternatively if it can efficiently activate factor X that binds directly to the membrane nanodomain adjacent to tissue factor. We show that full proteolytic activity of the factor VIIa-tissue factor complex requires extremely high local concentrations of anionic phospholipids, and furthermore that a large pool of membrane-bound factor X is not required to support sustained catalysis. These findings provide new insights, at the nanoscale, into the event that triggers the death of most people-the initiation of thrombosis.
Examples abound of membrane-bound enzymes for which the local membrane environment plays an important role, including the ectoenzyme that triggers blood clotting: the plasma serine protease, factor VIIa, bound to the integral membrane protein, tissue factor. The activity of this enzyme complex is markedly influenced by lipid bilayer composition, and furthermore, tissue factor partitions into membrane microdomains on some cell surfaces. Unfortunately, little is known about how membrane microdomain composition controls factor VIIa-tissue factor activity, since reactions catalyzed by membrane-tethered enzymes are typically studied under conditions in which the experimenter cannot control the composition of the membrane in the immediate vicinity of the enzyme. In order to overcome this problem we used a nanoscale approach that afforded complete control over the membrane environment surrounding tissue factor, by assembling the factor VIIa-tissue factor complex on stable bilayers containing 67±1 phospholipid molecules per leaflet (Nanodiscs). We investigated how local changes in phospholipid bilayer composition modulate the activity of the factor VIIa-tissue factor complex. We also addressed whether this enzyme requires a pool of membrane-bound protein substrate (factor X) for efficient catalysis, or alternatively if it can efficiently activate factor X that binds directly to the membrane nanodomain adjacent to tissue factor. We show that full proteolytic activity of the factor VIIa-tissue factor complex requires extremely high local concentrations of anionic phospholipids, and furthermore that a large pool of membrane-bound factor X is not required to support sustained catalysis. These findings provide new insights, at the nanoscale, into the event that triggers the death of most people-the initiation of thrombosis.
In both normal hemostasis and many lifethreatening thrombotic diseases, blood clotting is triggered when tissue factor (TF) 3 , an integral membrane protein, binds the plasma serine protease, factor VIIa (fVIIa) (1) . The resulting two-subunit, membrane-bound enzyme, TF:VIIa, activates the plasma zymogens, factors IX (fIX) and X (fX), by limited proteolysis. Erwin Chargaff (of nucleic acids fame) demonstrated in the 1940s that TF procoagulant activity requires it to be associated with phospholipids, and research over the ensuing decades demonstrated that TF is a membrane-spanning protein that must be incorporated into bilayers containing anionic phospholipids for optimal activity (reviewed by Bach (2)). Despite this extensive history, we still have an indistinct picture of how anionic phospholipids contribute so profoundly to the enzymatic activity of membrane-bound protease complexes involved in blood clotting (3) .
Membranes composed of mixed phospholipids (and other lipids) can form membrane microdomains with locally different surface properties. A noted example is the formation of cholesterol-and sphingolipid-rich lipid rafts and caveolae on cell surfaces (4, 5) . Experiments using giant unilamellar vesicles have shown that even liposomes containing simple binary mixtures of neutral and anionic phospholipids spontaneously form anionic 2 phospholipid-rich membrane microdomains in the presence of plasma concentrations of Ca 2+ , which is even more pronounced in the presence of membrane-binding proteins (6, 7) . Thus, anionic phospholipids were shown to coalesce, via lateral diffusion over relatively large distances, into subdomains several µm in size. These and other studies have demonstrated that local membrane microenvironments can differ dramatically from the average composition of the membrane even in relatively "simple" model membranes.
Most clotting proteins bind reversibly and in a Ca 2+ -dependent manner to bilayers containing anionic phospholipids-with phosphatidylserine (PS) being most active. Local differences in membrane microdomain properties mean that specific proteins may tend to partition into or out of such microdomains, and so the lipid composition in the immediate vicinity of membrane-bound protease-cofactor complexes may be expected to profoundly influence their enzymatic activities. For example, TF-bearing microparticles have been reported to arise from lipid rafts (8) , and depletion of cholesterol from cell membranes impairs functional TF expression in fibroblasts (9) . TF has also been reported to associate with caveolae on some cell surfaces (10) (11) (12) . The mechanisms by which specific plasma membrane domains may regulate the rate of clotting reactions are largely unknown, however. Membrane-binding protein substrates such as fX are known to partition between the solution phase and the membrane surface, and most likely they also partition into specific membrane microdomains. We therefore hypothesize that blood clotting reactions such as the activation of fX by the TF:VIIa complex occur preferentially, or at least with greatest efficiency, within membrane microdomains that have locally very high PS content.
fX molecules bound to the membrane may translate on the membrane via lateral diffusion, effectively skating or hopping along the surface. This leads to at least two different possible mechanisms by which protein substrates such as fX can encounter the TF:VIIa complex. In one mechanism, solution-phase fX binds directly to the membrane-bound TF:VIIa complex, whereupon it is activated to fXa via limited proteolysis. In another mechanism, membrane-bound fX molecules that are translating along the membrane surface (via lateral diffusion or hopping) encounter the TF:VIIa complex.
Several studies have addressed the relative importance of these two modes of substrate delivery to the TF:VIIa complex, typically by incorporating TF into liposomes of defined phospholipid composition, assembling the TF:VIIa complex, and then quantifying rates of fX activation. These approaches have allowed somewhat indirect inferences to be made regarding the choice of solution-phase versus membrane-bound fX as the preferred substrate, in which the investigators systematically vary the liposome concentration and also use competing membrane-binding proteins.
Using such approaches, some investigators have concluded that the membranebound pool of fX is the preferred substrate (13), while others have concluded the opposite-that solution-phase fX is the preferred substrate for the TF:VIIa complex (14, 15) .
In this study, we tested the concept that the local membrane nanoenvironment surrounding coagulation protease-cofactor complexes controls both their assembly and catalytic efficiencies toward membrane-bound protein substrates. We approached this by incorporating TF into nanoscale phospholipid bilayers that allow rigorous control of the local membrane microenvironment. This was accomplished using a unique system of stable nanoscale phospholipid bilayers, termed Nanodiscs (16), as a platform for studying membrane-protein interactions. Watersoluble Nanodiscs are produced by a self-assembly process resulting in a nanoscale lipid bilayer (about 8 nm in diameter) encircled and stabilized by two copies of an amphipathic helical protein termed membrane scaffold protein (MSP). This self-assembly is reproducible and efficient, yielding monodisperse preparations of supported lipid bilayers that are extremely stable and that exhibit lipid fluidity comparable to liposomes (17, 18) . Moreover, heterologous membrane-spanning proteins can also be incorporated efficiently into these supported nanobilayers during self-assembly (19, 20) . By embedding TF into nanoscale lipid bilayers, we can preclude long-distance (µm scale) recruitment of PS molecules into membrane domains with locally high or low PS content. Instead, the composition of the membrane nanodomain immediately surrounding the TF:VIIa complex is under tight experimental control.
Using this system, we report that full TF:VIIa proteolytic activity required extremely high local concentrations of anionic phospholipids, and furthermore that a large pool of membrane-bound fX was not required to support efficient catalysis.
Experimental Procedures
Materials-Phosphatidylcholine (PC; 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and PS (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine) were from Avanti Polar Lipids (Alabaster, AL), fVIIa was from American Diagnostica (Greenwich, CT) and fX was from Enzyme Research Laboratories (South Bend, IN). Recombinant human TF (21) and MSP (16) were expressed in E. coli and purified as described.
Reconstitution of Recombinant TF into Liposomes and Nanodiscs-TF was incorporated into liposomes as described (21) , using 15 mM sodium deoxycholate as the detergent. TF was incorporated into Nanodiscs as described for the incorporation of β 2 -adrenergic receptors into Nanodiscs (19) with the following modifications: PC and PS (5.2 mM total phospholipid) were dissolved in 10.4 mM sodium deoxycholate in TBS (50 mM Tris-HCl, pH 7.4, 150 mM NaCl), after which MSP and TF were added to yield phospholipid:MSP molar ratios ranging from 65:1 to 70:1, and MSP:TF molar ratios of 20:1. Because each Nanodisc contains two MSP proteins, this large excess of MSP to TF results in an average of one TF molecule per ten Nanodiscs, in order to minimize the occurrence of more than one TF molecule per Nanodisc. As previously described (19) , detergent was removed using BioBeads® SM-2 (Bio-Rad; Hercules, CA) and selfassembled Nanodiscs were isolated using size exclusion chromatography. TF-free Nanodiscs were also prepared using essentially the same methods but omitting TF.
Characterization of Nanodiscs-The phospholipid content of purified Nanodisc preparations was quantified by incorporating traces of 3 H-PS during self-assembly, then determining the 3 H-PS content by scintillation counting and the total phospholipid content by inorganic phosphate analyses following complete oxidation. Total TF concentrations in liposomes and Nanodiscs were determined by ELISA after detergent solubilization (21) . Concentrations of functional (available) TF in TF-liposomes and TFNanodiscs were determined enzymatically by titration with a fixed concentration of fVIIa (22) . With TF-Nanodiscs, TF concentrations measured by ELISA agreed with the results of fVIIa titrations within experimental error (not shown), indicating that essentially 100% of the TF molecules in TF-Nanodiscs were functional. With TF-liposomes, approximately 50 to 60% of the TF molecules measured by ELISA were available by fVIIa titration (not shown), attributable to some TF molecules facing the lumen of the liposomes. TF concentrations are given throughout as the concentration of available TF. To demonstrate the presence of only one TF molecule per TFNanodisc, TF-Nanodiscs were first purified from TF-free Nanodiscs by affinity chromatography using immobilized HPC4 antibody directed against an epitope tag at the N-terminus of TF as previously described (23), but omitting the 1M NaCl wash step. The stoichiometries of TF and MSP protein in preparations of TF-Nanodiscs were then assessed via quantitative SDS PAGE.
Assessment of Nanodisc Aggregation in the Presence of Ca
2+ -TF-free Nanodiscs containing 0 to 100% PS were diluted in TBS with or without 2.5 mM CaCl 2 and incubated for a minimum of 20 min. This process was also performed on TFNanodiscs containing 70% PS. The samples were then resolved by size exclusion chromatography on a Superdex 200 column (GE Healthcare BioSciences, Piscataway, NJ) monitored by A 280 ; no evidence of aggregation was obtained for any of the TF-free or TF-containing Nanodisc preparations (not shown). TF-free Nanodiscs were also analyzed by dynamic light scattering in which intensity autocorrelation functions of micromolar quantities of TF-free Nanodiscs in TBS with or without 2.5 mM CaCl 2 were quantified at ambient temperature using a Brookhaven Instruments BI-200 SM goniometer with a Lexel model 95 argonion laser (514 nm) at a scattering angle of 90°. A photomultiplier tube was used to measure light intensity, with signal processing by a BI-9000AT digital correlator. Using the Siegert relationship, the intermediate scattering function, g, was determined from the measured intensity autocorrelation function, G(τ) = B(1 + f 2 [g(τ)] 2 ), where B is the background intensity, f is an optical constant based on the measuring instrument, and τ is the decay time (24) .
Measuring the Binding of fVIIa to TFNanodiscs and Rates of fX Activation-Binding affinities of fVIIa for TF in liposomes or
Nanodiscs were quantified using the TF-dependent increase in fVIIa enzymatic activity as described (25). Initial rates of fX activation by the TF:VIIa complex (assembled either on TF-liposomes or TF-Nanodiscs) were quantified using a continuous fX activation assay as previously described (25). Rates of fXa generation were measured over a 20 min period and in all cases were linear over the entire time course. In all kinetic experiments, the final TF concentration was 5 pM in both the TFNanodisc and TF-liposome systems. For TFNanodisc experiments, a molar ratio of 1 TFNanodisc: 9 TF-free Nanodiscs was used, yielding final concentrations of 50 pM Nanodiscs and 6.7 nM phospholipid. For TF-liposome experiments, the final phospholipid concentration was 65 nM. K m and k cat values were calculated by fitting the Michaelis-Menten equation to the rate data using nonlinear regression.
Surface Plasmon Resonance AnalysesBinding of fX to Nanodiscs containing varying mol% PS was quantified by surface plasmon resonance using a Biacore 3000 instrument. NTA Biacore sensor chips were charged with Ni 2+ according to the manufacturer's recommendations, after which Nanodiscs were immobilized on the NTA-Ni 2+ chip surface via the oligohistidine tag located on MSP. An empty NTA-Ni 2+ channel was used to subtract changes in resonance units (RU) due to the refractive index of the protein solution and any non-specific binding. Running buffer (10 mM HEPES-NaOH pH 7.4, 150mM NaCl, 2.5mM CaCl 2 ) was flowed at 5µL/min. Nanodiscs were loaded onto each channel in calcium-free running buffer until a signal of 800 RU was achieved, after which a steady baseline was established in running buffer. Increasing concentrations of fX were injected in running buffer and the maximal response above the baseline upon reaching steady state was recorded for each injected concentration. The maximal RU values achieved at each fX concentration were then used to evaluate the affinity (K d ) of fX for the nanoscale bilayers. This approach avoids potential limitations from analyzing association and dissociation rate data due to mass transport-limited rates of analyte association and analyte rebinding during the dissociation phase. At the end of each run, NTA chips were regenerated using a buffer containing 0.3 M EDTA, which successfully removed the Nanodiscs and all bound proteins. NTA sensor chips were reused for multiple binding experiments with no observed loss of function.
RESULTS AND DISCUSSION
In this study we examined how changes in the local composition of the membrane immediately surrounding the TF:VIIa complex modulated its ability to proteolytically activate its membrane-binding substrate, fX. We approached this by embedding TF into supported nanoscale lipid bilayers (Nanodiscs), in order to preclude long-distance recruitment of PS molecules into membrane subdomains with locally high or low PS contents. As presented below, we then measured the ability of the TF:VIIa complex to assemble and function within these nanoscale bilayers as the local PS content was altered over a very broad range (0 to 90% PS). In order to show the general trends observed with conventional liposome-based approaches, we obtained data with the TF:VIIa complex assembled on TF-liposomes of varying phospholipid composition (from 0 to 40% PS).
For the reasons outlined in the Introduction, however, it is not really possible to compare directly the results obtained using these two forms of TF, since we have no experimental control over the local PS content surrounding the TF:VIIa complex assembled on TF-liposomes. Furthermore, because conventional liposomes containing extremely high PS contents undergo vesicle fusion and collapse when exposed to mM concentrations of Ca 2+ (26), it is likewise not possible to study the effects of high total PS content in conventional TF-liposomes.
Size Considerations-In order to successfully investigate the activation of blood coagulation using the Nanodisc system, it was essential to demonstrate that the enclosed nanobilayer has sufficient room to assemble the TF:VIIa complex and also to productively bind at least one substrate (fX) molecule. The crosssectional area of the membrane-binding domain of fVIIa (the Gla domain) is ~3.9 nm 2 (27) , and the surface area of a phospholipid headgroup is ~0.7 nm 2 (28), so the Gla domain covers roughly six phospholipid molecules. The nanobilayers in these Nanodiscs, which contain 67±1 phospholipid molecules per leaflet (see below), should therefore have room to bind as many as ten Gla domains per leaflet. But the cross-sectional area of the widest part of the TF:VIIa complex-near the globular fVIIa protease domain-is 16 to 18 nm 2 (27) , or enough to cover 23 to 26 phospholipid molecules. The relative sizes of these structures are displayed graphically in Fig. 1A , in which the crystal structure of the TF:VIIa complex is placed, to scale, on a schematic of the 8 nm supported bilayer contained within a Nanodisc. Although the widest part of the TF:VIIa complex is around the globular protease domain of fVIIa, the two points of membrane contact in the TF:VIIa complex are considerably smaller. Furthermore, since the supported bilayer in Nanodiscs has a boundary, portions of the TF:VIIa complex located near the protease domain could project beyond the edge of the bilayer. This is demonstrated graphically in Figs. 1B and C, in which a "top" view of the crystal structure of the TF:VIIa complex is placed, to scale, on an 8 nm diameter circle representing the size of the supported nanobilayer (29) . In this case, over 60% of the surface of the leaflet remains available for binding fX molecules. The three-dimensional structure of zymogen fX is not known with certainty but fX is highly homologous to fVII (including its Gla domain) and likely has a similar cross-sectional area. With 60% or more of the disc surface still available on discs containing the TF:VIIa complex, as many as six fX molecules could also possibly bind to the remaining leaflet. However, factors such as the mobility of TF:VIIa in the lipid bilayer and the need for fX to bind in a specific orientation relative to TF:VIIa might reduce the available area somewhat. Thus, the lipid bilayer in a Nanodisc is large enough to assemble the TF:VIIa complex and also bind at least one fX molecule, and perhaps as many as five or six.
Preparation and Characterization of TFNanodiscs-Nanodiscs and TF-Nanodiscs were prepared using varying proportions of PC and PS, ranging from 0 to 100% PS.
They were monodisperse as assessed by gel filtration and light scattering, and contained one TF molecule per disc (for TF-Nanodiscs; Fig. 2A ). These Nanodisc preparations contained a mean of 67±1 phospholipid molecules per leaflet and had final proportions of PC and PS that faithfully reflected the input PC/PS content (Fig. 2B) . In order to test the hypothesis that locally high PS content enhances TF function, we needed to prepare Nanodiscs containing very high mol% PS. This can be highly problematical when preparing liposomes, since exposing liposomes with very high PS content to plasma concentrations of Ca 2+ leads to liposome aggregation, fusion and/or collapse (26) . Accordingly, we investigated the aggregation state of Nanodiscs containing 0 to 100% PS. In buffered solutions containing 150 mM NaCl and 2.5 mM CaCl 2 , Nanodiscs containing 0 to 90 mol% PS were monodisperse as assessed by dynamic light scattering (Fig. 3A and B) and gel filtration (not shown). On the other hand, only Nanodiscs containing 100% PS showed limited but detectable aggregation in the presence of Ca 2+ , but not in its absence (Fig. 3C) .
Binding of fX to Nanoscale BilayersIncorporating PS into TF-liposomes of mixed phospholipid content enhances TF:VIIa proteolytic activity, with maximal rates of fX activation generally achieved at 10 to 40% PS (30, 31) . This rate enhancement requires the presence of the Gla domain on fX, which mediates reversible binding of this protein to membranes containing PS. Accordingly, we used surface plasmon resonance to examine the ability of nanoscale bilayers of varying PS content to bind fX. Fig. 4A shows plots of the maximal RU values obtained at steady state for binding of fX to Nanodiscs of varying PS content, plotted as amount bound versus fX concentration. Negligible quantities of fX bound to Nanodiscs containing only PC, but as the PS content of the nanobilayers increased, fX was observed to bind to Nanodiscs in a saturable, concentration-dependent manner in which both the affinity and total amount of fX binding increased with increasing PS content. The single-site ligand binding equation fit very well to the data at all PS contents (Fig. 4A) , from which K d values were obtained. Binding affinities increased (i.e., K d values decreased) as a function of increasing PS content (Fig. 4B) , with an almost linear dependence of binding free energy on PS content (Fig. 4C) . The K d values obtained with Nanodiscs containing 54 or 67 PS molecules per leaflet (i.e., 80 or 100% PS) were in the range of literature values for fX binding to liposomes containing 20 to 30% PS (32, 33) . Interestingly, the amount of fX bound to Nanodiscs at saturation increased steadily as the PS content increased (Fig. 4D) , and indeed previous studies using liposomes have estimated that one fX molecule engages approximately five PS molecules (32) . Thus, Nanodiscs with very high PS content will contain more fX binding sites, and as the PS molecules are more closely packed within the bilayer they will bind fX with higher affinity.
As demonstrated above, there is theoretically sufficient room on Nanodiscs to bind up to ten fX molecules per leaflet. Stoichiometric calculations of fX molecules bound per Nanodisc can be estimated from SPR signals if the bound molecules have equivalent impact on the refractive index.
Previous studies have shown that phospholipid bilayers in the fluid phase have similar refractive indices compared with protein solutions (34, 35) . Therefore, at saturation the molar ratio of fX to Nanodiscs equals (RU fX /RU discs )*(MW discs /MW fX ). In our experiments, 800 RU of Nanodiscs were loaded onto the sensor chips. The maximal amount of fX bound at steady state increased linearly as a function of the PS content of the Nanodiscs, with 5100 RU of fX bound at saturation to discs containing 100% PS. Using masses of 154 kDa for Nanodiscs containing 100% PS (i.e., 134 PS molecules at 784 Da each and 2 MSP molecules at 24.7 kDa each) and 59 kDa for fX, we calculated 16.6 fX molecules bound per Nanodisc (i.e., 8.4 fX bound per leaflet) at saturation (Fig. 4D) . This agrees well with the maximal estimate of about ten fX molecules per leaflet based solely on the surface area of a Gla domain.
Using 0.7 nm 2 /phospholipid, this corresponds to a surface coverage of 29 pmol fX/cm 2 , which is significantly higher than reported in the literature in experiments using fX binding to liposomes (33, 36) . We attribute this apparently higher coverage to the fact that Nanodiscs have boundaries beyond which the globular portions of these proteins can project (as demonstrated graphically by the TF:VIIa complex in Fig. 1) , and also to the very high local PS content of these Nanodiscs (leading to a higher density of potential fX binding sites).
Assembling the TF:VIIa Complex on Nanoscale Bilayers-Most of the binding energy of the TF:VIIa complex comes from proteinprotein interactions, but some additional binding energy is provided by protein-membrane interactions between the fVIIa Gla domain and anionic phospholipids, thereby reducing the K d for assembling TF:VIIa from ~2 nM to less than 50 pM (30) . In the present study we found that binding of fVIIa to TF in liposomes or Nanodiscs was enhanced as the PS content of the bilayer increased, achieving K d values below 30 pM for both presentations of TF (Fig. 5) . Interestingly, the tightest binding of fVIIa to TF-Nanodiscs was observed at the highest PS contents (70 and 90% PS). This is consistent with the notion that locally very high PS content favors the binding of Gla domain-containing proteins such as fVIIa to membrane surfaces. This also suggests that the TF:VIIa complex will have highest affinity for, and therefore likely to partition into, membrane subdomains with locally very high PS content. Our findings also demonstrate that it is possible to assemble fully functional TF:VIIa complexes on 8 nm diameter bilayers.
Local PS Composition Influences Rates of fX Activation by TF:VIIa-As expected from many previous studies, increasing the PS content of TFliposomes decreased the apparent K m for fX activation by TF:VIIa (Fig. 6A) . With TFNanodiscs, the K m for fX decreased monotonically as the PS content increased (Fig. 6B) , paralleling the PS dependence of fX binding to Nanodiscs (cf. Fig. 4B) . Interestingly, the lowest K m values with TF-Nanodiscs were obtained at the highest PS content (containing 60 PS molecules per leaflet, or 90% PS). It should also be noted that these kinetic experiments employ 50 pM Nanodiscs, each of which can bind a maximum of about 16.6 fX molecules. Thus, the maximal concentration of membrane-bound fX is about 0.8 nM, which is far below the fX concentrations used in our kinetic analyses. For this reason, the concentration of total fX and free fX are essentially identical in our kinetic studies using TF-Nanodiscs.
We obtained similar apparent k cat values when TF:VIIa complex was assembled on TFNanodiscs and TF-liposomes, ranging from about 1 to 4 s -1 ( Fig. 6C and D) , although the trends in k cat values differed somewhat between TFliposomes and TF-Nanodiscs as the PS content increased. With TF-liposomes the second-order rate constant for fX activation (k cat /K m ) increased continuously with increasing %PS from 10 to 40% PS (Fig. 6E) , and with TF-Nanodiscs it increased from 10 to 70% PS (equivalent to 47 PS molecules per leaflet; Fig. 6F ). Taken together, these results indicate that the TF:VIIa complex is most active when the local PS content is very high (70% PS and above).
Mechanisms of Substrate Presentation to TF:
VIIa-Our findings demonstrate that the TF:VIIa enzyme complex can efficiently activate its natural protein substrate, fX, even when this membrane-bound enzyme complex is constrained within a nanoscale lipid bilayer consisting of only ~67 phospholipid molecules per leaflet. From indirect analyses using TF-liposomes, some have suggested that solution-phase fX may be the preferred substrate for TF:VIIa (14, 15) , while others have argued that the pool of membranebound fX represents the preferred substrate (13). The TF:VIIa complex assembled on Nanodiscs, unlike the situation on liposomes, does not have access to a large pool of membrane-bound fX molecules that can be used to deliver substrate to the enzyme over long distances by lateral diffusion or hopping. Instead, the tiny membrane surface corralled inside the Nanodisc can bind at most five or six fX molecules when the TF:VIIa complex is present, as discussed above. Given the rates of fX activation observed in Fig. 6 , it should take only two or three seconds to convert all these membrane-bound fX molecules to fXa. Instead, we observed linear rates of fX activation that were sustained over 20 min. At a k cat of 2 s -1 , each TF:VIIa complex activates 2400 fX molecules during this 20 min time course. Therefore, the TF:VIIa complex must rely on continuous binding of substrate (fX) to, and dissociation of product (fXa) from the nanobilayer, in order to allow such sustained rates of fX activation. On the other hand, the much larger membrane surface on liposomes can bind many hundreds of fX molecules, theoretically allowing the TF:VIIa complex to choose between the membrane-bound pool of fX molecules laterally diffusing on the membrane surface or solution-phase fX molecules that bind directly to TF:VIIa or to the membrane immediately adjacent to complex. The fact that k cat values obtained with TF-Nanodiscs rival those of TF-liposomes indicates that the TF:VIIa complex is not absolutely dependent on a large, preexisting pool of membrane-bound fX to serve as substrate.
With TF-liposomes, k cat values increased as the %PS increased (up to 40% PS), but TFNanodiscs did not exhibit this behavior. Hathcock et al. (33, 37) proposed that removal of fXa from the vicinity of the TF:VIIa complex by lateral diffusion on the membrane surface is likely the rate-limiting process controlling the apparent k cat . However, this mechanism of product removal from the TF:VIIa complex is likely to be less effective when the TF:VIIa complex is constrained within nanoscale bilayers.
Coagulation serine proteases and the corresponding protease-cofactor complexes (including TF:VIIa) have evolved exosites to increase substrate specificity (38) . Exosites are distinct binding sites lying outside the protease's active site that can enhance binding of protein substrates, inhibitors and other regulatory molecules. In fact, exosites may be located on the protease, the protein cofactor, or both. We propose that a small patch of anionic phospholipids located on the membrane surface in the immediate vicinity (i.e., within a few nm) of TF serves as an additional exosite to enhance the binding affinity of protein substrates like fIX and fX to the TF:VIIa complex. This contributes in an important way to the substrate specificity of this extremely selective activator of the blood clotting cascade. FOOTNOTES * We thank William Smith and Charles Zukoski for advice on dynamic light scattering measurements, Liping Wang for advice on surface plasmon resonance measurements, Brad Schwartz for comments on the manuscript, and Guoyu Li and Collin Waters for excellent technical assistance. This work was supported by grants HL47014 from NIH and 06-2328 from the Roy J. Carver Charitable Trust (to J.H.M.); GM33775 from NIH and SBCNW0830 520N602 from NSF (to S.G.S.); and Predoctoral Fellowship 0610028Z from the American Heart Association (to V.S.P.). V.S.P., S.G.S., and J.H.M. are coinventors on patents and patent applications owned by the University of Illinois at Urbana-Champaign pertaining to Nanodiscs. S.G.S. has a financial interest (but no managerial or operational role) in Nanodisc, Inc., to whom some of the patents on Nanodisc technology are licensed. (27)) is placed, to scale, on a schematic of the 8 nm diameter bilayer in a Nanodisc (16) . TF is colored brown, fVIIa is blue (with active site inhibitor in white), phospholipid headgroups are depicted as red spheres, and amphipathic helices of the encircling MSP are depicted as purple cylinders. B, "Top" view of the TF:VIIa complex placed near the edge of an 8 nm diameter bilayer (represented by a green circle), with only the Gla domain of fVIIa and the "bottom" portion of TF rendered as space filling atoms; the rest of the TF:VIIa structure (except the active site inhibitor) is rendered as wires. C, Same view as in panel B, but with the entire TF:VIIa complex rendered as spacefilling atoms. FIGURE 2. Nanodisc composition. A, Number of TF molecules per Nanodisc. A standard curve was prepared by resolving samples, in duplicate, containing known quantities of purified TF and MSP (first eight lanes) on SDS-PAGE, staining the gel with Coomassie blue, and digitizing using a scanning densitometer (analyzed using Scion Image software, Scion Corporation, Frederick, MD). Purified TFNanodiscs were resolved on the same gel (rightmost two lanes) and quantified in parallel with the standards, yielding a determination of 0.51 TF per MSP molecule, or 1.02 TF molecules per TFNanodisc. B, PS content of Nanodiscs. Nanodiscs of varying PS compositions were prepared, to which trace amounts of 3 H-PS were added during self-assembly. Scintillation counting was used to determine PS recovery. The line is a plot of y = x, showing that the %PS in Nanodiscs is essentially identical to that of the initial lipid mixture. Inorganic phosphate analyses following complete oxidation of the samples demonstrated that the mean molar ratio of phospholipid to MSP was 67(±1):1. Since each Nanodisc contains two MSP molecules, the mean phospholipid content was therefore 134±2 phospholipid molecules per Nanodisc. 
